Cardiac safe hematopoietic stem cell transplantation protocol for systemic sclerosis with myocarditis—a two-step approach-Reference-Cited by-同舟云学术

Cardiac safe hematopoietic stem cell transplantation protocol for systemic sclerosis with myocarditis—a two-step approach

Published:2024-05-13 Issue: Volume: Page:
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:

Author:

Keret Shiri¹²^ORCID,Chutko Boris²³⁴,Dobrecky-Mery Idit²⁴,Wolak Arik³,Hardak Emilia²⁵,Slobodin Gleb¹²,Shouval Aniela¹²,Henig Israel²⁶,Zuckerman Tsila²⁶,Yehudai-Ofir Dana²⁶,Farge Dominique⁷⁸⁹,Rimar Doron¹²^ORCID

Affiliation:

1. Rheumatology Unit, Bnai Zion Medical Center , Haifa, Israel

2. Ruth and Bruce Rappaport Faculty of Medicine, Technion , Haifa, Israel

3. Cardiology, Shaare Zedek Medical Center , Jerusalem, Israel

4. Cardiology, Bnai Zion Medical Center , Haifa, Israel

5. Pulmonary Unit, Bnai Zion Medical Center , Haifa, Israel

6. Department of Hematology and Bone Marrow Transplantation, Rambam Medical Center , Haifa, Israel

7. Department of Internal Medicine: CRMR MATHEC, Maladies Auto-Immunes et Thérapie Cellulaire, Centre de Référence des Maladies Auto-Immunes Systémiques Rares d’Ile-de-France, FAI2R, Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris , Paris, France

8. Université de Paris-Cité , Paris, France

9. Department of Medicine, McGill University , Montreal, QC, Canada

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/keae268/57861142/keae268.pdf

Reference7 articles.

1. Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial;Burt;Lancet,2011

2. Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial;van Laar;JAMA,2014

3. Myeloablative autologous stem-cell transplantation for severe scleroderma;Sullivan;N Engl J Med,2018

4. Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysis;Burt;Lancet,2013

5. Cardiopulmonary assessment of patients with systemic sclerosis for hematopoietic stem cell transplantation: recommendations from the European Society for Blood and Marrow Transplantation Autoimmune Diseases Working Party and collaborating partners;Farge;Bone Marrow Transplant,2017